ASIA PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026
Asia Pacific ophthalmology drugs & devices market is expected to grow at the highest CAGR of 6.22%% over the forecast period of 2018-2026. The ophthalmology drugs and devices market is driven by an increase in FDA approvals, which give a boost to the adoption of drugs and devices and rise in surgeries in ophthalmology market due to the high dominance of refractive errors.
ASIA PACIFIC OPTHALMOLOGY DRUGS & DEVICES MARKET FORECAST 2018-2026
Asia Pacific ophthalmology drugs & devices market is expected to grow at the highest CAGR of 6.22%% over the forecast period of 2018-2026. The ophthalmology drugs and devices market is driven by an increase in FDA approvals, which give a boost to the adoption of drugs and devices and rise in surgeries in ophthalmology market due to the high dominance of refractive errors.
The countries analyzed in the Asia-Pacific region are India, China, Japan, South Korea and Australia. The South Korean ophthalmology drugs and devices market are expected to register the highest CAGR over the forecast period. Major factors driving the ophthalmology drugs market in South Korea are the growing ageing population, increasing healthcare expenditures and rising prevalence of eye related diseases such as glaucoma, low vision, dry eye disease, etc.
Well-known drugs are going off patent, and key players are being affected by the delay in new drugs coming into this market. Despite this fact, companies like Sun Pharmaceuticals Industries Ltd, GlaxoSmithKline, Pfizer, Johnson & Johnson Inc, Ziemer Group Holding Ag, Novartis International Ag, Essilor International S.A, Allergan Inc, Santen Pharmaceutical Co Ltd, Roche Holding Ag, and Valent Pharmaceuticals International Inc are engaged in this market.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- VISION CARE DEVICES ARE DOMINATING THE MARKET
- GLAUCOMA DRUGS ARE MAJORLY USED
- RISING PREVALENCE OF EYE RELATED DISEASES
- MARKET DETERMINANTS
- MARKET DRIVERS
- INCREASING PREVALENCE OF DIABETES INCREASES THE PROBABILITY OF OPHTHALMIC DISORDERS
- TECHNOLOGICAL ADVANCEMENT
- INCREASE IN HEALTHCARE EXPENDITURE
- MARKET RESTRAINTS
- RENOWNED DRUGS GOING OFF-PATENT
- DELAY IN DRUG APPROVALS
- AWARENESS RELATED TO OPHTHALMOLOGY DRUGS ARE LOW
- MARKET OPPORTUNITIES
- INCREASE IN DISORDER SYMPTOM AND IMPROVED DIAGNOSIS LEADING TO HIGHER TREATMENT RATES
- INCREASING DEMAND FOR INTRAOCULAR LENSES AND PHACOEMULSIFICATION DEVICES
- MARKET CHALLENGES
- VARIOUS RISK AND COMPLICATIONS ASSOCIATED WITH THE TREATMENT OF OCULAR DISEASES
- MARKET DRIVERS
- MARKET SEGMENTATION
- MARKET BY DRUGS AND DEVICES 2018-2026
- DEVICES
- DIAGNOSTIC & MONITORING EQUIPMENT
- OPTICAL COHERENCE TOMOGRAPHY
- OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
- FUNDUS CAMERA MARKET
- OPHTHALMOSCOPES
- RETINOSCOPE
- PACHYMETER
- WAVEFRONT ABERROMETERS
- PERIMETERS/VISUAL FIELD ANALYZER
- AUTOREFRACTORS/PHOROPTER
- SPECULAR MICROSCOPE
- CORNEAL TOPOGRAPHERS
- OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
- SURGERY DEVICE
- CATARACT SURGERY DEVICES
- GLAUCOMA SURGERY DEVICES
- REFRACTIVE SURGERY DEVICES
- VITREORETINAL SURGERY DEVICES
- VISION CARE
- DIAGNOSTIC & MONITORING EQUIPMENT
- DRUGS
- GLAUCOMA DRUG
- RETINAL DISORDER DRUG
- DRY EYE DRUG
- ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
- DEVICES
- MARKET BY DRUGS AND DEVICES 2018-2026
- KEY ANALYTICS
- PORTER’S FIVE FORCES ANALYSIS
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIER
- THREATS OF NEW ENTRANTS
- THREATS OF SUBSTITUTES
- COMPETITIVE RIVALRY
- VALUE CHAIN ANALYSIS
- RESEARCH AND DEVELOPMENT
- MANUFACTURING
- DISTRIBUTORS
- END USERS
- KEY BUYING CRITERIA
- COST
- EFFICACY
- ACCESSIBILITY
- INNOVATION
- SUPPLY CHAIN ANALYSIS
- SUPPLIERS
- MANUFACTURERS
- DISTRIBUTORS AND RETAILERS
- END USERS
- REGULATORY FRAMEWORK
- PORTER’S FIVE FORCES ANALYSIS
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- REST OF APAC
- ASIA PACIFIC
- COMPANY PROFILES
- COMPETITIVE ANALYSIS
- MARKET SHARE ANALYSIS
- TOP COMPANIES
- ESSILOR INTERNATIONAL S.A. (FRANCE)
- JOHNSON & JOHNSON INC. (U.S.)
- ALLERGAN PLC (U.S.)
- NOVARTIS INTERNATIONAL AG (SWITZERLAND)
- VALENT PHARMACEUTICALS INTERNATIONAL INC. (U.S.)
- ALLERGAN INC.
- COMPANY OVERVIEW
- PRODUCT & SERVICES
- SWOT ANALYSIS
- STRATEGIC INITIATIVES
- BAYER
- COMPANY OVERVIEW
- PRODUCT & SERVICES
- SWOT ANALYSIS
- STRATEGIC INITIATIVES
- CARL ZEISS AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SWOT ANALYSIS
- STRATEGIC INITIATIVE
- ESSILOR INTERNATIONAL S.A.
- COMPANY OVERVIEW
- PRODUCT & SERVICES
- SWOT ANALYSIS
- STRATEGIC INITIATIVE
- GLAXOSMITHKLINE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SWOT ANALYSIS
- JOHNSON & JOHNSON INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- NOVARTIS INTERNATIONAL AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- PFIZER
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- ROCHE HOLDING AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- SANTEN PHARMACEUTICAL CO., LTD.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- SUN PHARMACEUTICALS INDUSTRIES, LTD
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- VALENT PHARMACEUTICALS INTERNATIONAL INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- ZIEMER GROUP HOLDING AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- COMPETITIVE ANALYSIS
LIST OF TABLES
TABLE 1 ASIA PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026
TABLE 2 COMMON CAUSES OF LOSS OF VISION IN THE ELDERLY
TABLE 3 SELECTED LIST OF GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS
TABLE 4 EYE DRUGS GONE OFF-PATENT
TABLE 5 ASIA PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2018-2026 ($ MILLION)
TABLE 6 ASIA PACIFIC OPHTHALMOLOGY DRUGS AND DEVICES MARKET IN DEVICES 2018-2026 ($ MILLION)
TABLE 7 ASIA PACIFIC DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT BY TYPES 2018-2026 ($ MILLION)
TABLE 8 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY 2018-2026 ($ MILLION)
TABLE 9 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 2018-2026 ($ MILLION)
TABLE 10 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2018-2026 ($ MILLION)
TABLE 11 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2018-2026 ($ MILLION)
TABLE 12 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2018-2026 ($ MILLION)
TABLE 13 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PACHYMETER 2018-2026 ($ MILLION)
TABLE 14 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS 2018-2026 ($ MILLION)
TABLE 15 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER 2018-2026 ($ MILLION)
TABLE 16 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER 2018-2026 ($ MILLION)
TABLE 17 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2018-2026 ($ MILLION)
TABLE 18 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2018-2026 ($ MILLION)
TABLE 19 ASIA PACIFIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2018-2026 ($ MILLION)
TABLE 20 ASIA PACIFIC DEVICES MARKET IN SURGERY DEVICE BY TYPES 2018-2026 ($ MILLION)
TABLE 21 ASIA PACIFIC SURGERY DEVICES MARKET IN CATARACT SURGERY DEVICES 2018-2026 ($ MILLION)
TABLE 22 ASIA PACIFIC SURGERY DEVICES MARKET IN GLAUCOMA SURGERY DEVICES 2018-2026 ($ MILLION)
TABLE 23 ASIA PACIFIC SURGERY DEVICES MARKET IN REFRACTIVE SURGERY DEVICES 2018-2026 ($ MILLION)
TABLE 24 ASIA PACIFIC SURGERY DEVICES MARKET IN VITREORETINAL SURGERY DEVICES 2018-2026 ($ MILLION)
TABLE 25 ASIA PACIFIC DEVICES MARKET IN VISION CARE MARKET 2018-2026 ($ MILLION)
TABLE 26 ASIA PACIFIC DRUGS AND DEVICES MARKET IN DRUGS BY TYPES 2018-2026 ($ MILLION)
TABLE 27 ASIA PACIFIC DRUGS MARKET IN GLAUCOMA DRUG 2018-2026 ($ MILLION)
TABLE 28 ASIA PACIFIC DRUGS MARKET IN RETINAL DISORDER DRUG 2018-2026 ($ MILLION)
TABLE 29 ASIA PACIFIC DRUGS MARKET IN DRY EYE DRUG 2018-2026 ($ MILLION)
TABLE 30 ASIA PACIFIC DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2018-2026 ($ MILLION)
TABLE 31 ASIA PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
LIST OF FIGURES
FIGURE 1 ASIA PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026
FIGURE 2 ASIA PACIFIC DRUGS AND DEVICES MARKET IN DEVICES 2018-2026 ($ MILLION)
FIGURE 3 ASIA PACIFIC DEVICES MARKET DIAGNOSTIC & MONITORING EQUIPMENT IN 2018-2026 ($ MILLION)
FIGURE 4 ASIA PACIFIC DEVICES MARKET IN SURGERY DEVICE 2018-2026 ($ MILLION)
FIGURE 5 ASIA PACIFIC DEVICES MARKET IN VISION CARE MARKET 2018-2026 ($ MILLION)
FIGURE 6 ASIA PACIFIC DRUGS AND DEVICES MARKET IN DRUGS 2018-2026 ($ MILLION)
FIGURE 7 ASIA PACIFIC DRUGS MARKET IN GLAUCOMA DRUG 2018-2026 ($ MILLION)
FIGURE 8 ASIA PACIFIC DRUGS MARKET IN RETINAL DISORDER DRUG 2018-2026 ($ MILLION)
FIGURE 9 ASIA PACIFIC DRUGS MARKET IN DRY EYE DRUG 2018-2026 ($ MILLION)
FIGURE 10 ASIA PACIFIC DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2018-2026 ($ MILLION)
FIGURE 11 ASIA PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
FIGURE 12 INDIA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
FIGURE 13 CHINA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
FIGURE 14 JAPAN OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
FIGURE 15 SOUTH KOREA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
FIGURE 16 AUSTRALIA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
FIGURE 17 REST OF APAC OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)
FIGURE 18 OPHTHALMOLOGY DEVICES COMPANY MARKET SHARE 2017 (%)
FIGURE 19 OPHTHALMOLOGY DRUGS COMPANY MARKET SHARE 2017 (%)
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- REST OF APAC
- ASIA PACIFIC
- MARKET SEGMENTATION
- MARKET BY DRUGS AND DEVICES 2018-2026
- DEVICES
- DIAGNOSTIC & MONITORING EQUIPMENT
- OPTICAL COHERENCE TOMOGRAPHY
- OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
- FUNDUS CAMERA MARKET
- OPHTHALMOSCOPES
- RETINOSCOPE
- PACHYMETER
- WAVEFRONT ABERROMETERS
- PERIMETERS/VISUAL FIELD ANALYZER
- AUTOREFRACTORS/PHOROPTER
- SPECULAR MICROSCOPE
- CORNEAL TOPOGRAPHERS
- OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
- SURGERY DEVICE
- CATARACT SURGERY DEVICES
- GLAUCOMA SURGERY DEVICES
- REFRACTIVE SURGERY DEVICES
- VITREORETINAL SURGERY DEVICES
- VISION CARE
- DIAGNOSTIC & MONITORING EQUIPMENT
- DRUGS
- GLAUCOMA DRUG
- RETINAL DISORDER DRUG
- DRY EYE DRUG
- ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
- DEVICES
- MARKET BY DRUGS AND DEVICES 2018-2026
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.